Lori M Minasian
Affiliation: National Institutes of Health
- Prevention and early detection clinical trials: opportunities for primary care providers and their patientsLeslie G Ford
Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA
CA Cancer J Clin 53:82-101. 2003....
- Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology ProgramLori M Minasian
Division of Cancer Prevention, U S National Cancer Institute, Rockville, Md Electronic address
Semin Oncol 42:748-63. 2015..These large cancer prevention studies, which have enrolled more than 80,000 volunteers, continue to contribute to our understanding of cancer development more than 10 years after they were closed. ..
- Health-related quality of life and symptom management research sponsored by the National Cancer InstituteLori M Minasian
Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7340, USA
J Clin Oncol 25:5128-32. 2007..The scope of NCI's research in symptom management and HRQOL is described with attention to its evolution over time and the next steps, through the Clinical Trials Working Group Recommendations...
- Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experienceDavid R Buchanan
National Cancer Institute, 6130 Executive Plaza, Rm 2149, Bethesda, MD 20892 7317, USA
J Clin Oncol 23:6682-9. 2005..To identify major research-design issues in proposals submitted by investigators in the Community Clinical Oncology Program (CCOP) for clinical trials of complementary and alternative medicine (CAM) for cancer-symptom management...
- Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translationAndrew N Freedman
National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7393, USA
J Natl Cancer Inst 102:1698-705. 2010....
- A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)Barbara K Dunn
Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland 20892, USA
Nutr Cancer 62:896-918. 2010..07, P = 0.16) were observed. SELECT data show that neither selenium nor vitamin E, alone or together, in the doses and formulations used, prevented prostate cancer in this heterogeneous population of healthy men...
- Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology ProgramLori M Minasian
Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA
Cancer 116:4440-9. 2010..By describing its keys to success, this article provides practical guidance to cancer-focused, provider-based research networks as well as those in other disciplines...
- Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology ProgramDavid R Buchanan
Division of Cancer Prevention, National Cancer Institute NIH, 6130 Executive Blvd, Room EPN 2149, Bethesda, MD 20892 7317, USA
J Clin Oncol 23:591-8. 2005..To examine how quality of life (QOL) is prospectively conceptualized, defined, and measured in the symptom management clinical trials supported by the National Cancer Institute Community Clinical Oncology Program (CCOP)...
- Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experienceWorta McCaskill-Stevens
Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
J Clin Oncol 23:5247-54. 2005..This article examines temporal trends in MBCCOP accruals to cancer prevention and control (CP/C) and cancer treatment trials and the racial distribution of study participants, along with the major factors affecting minority enrollment...
- Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer riskAlan R Kristal
Affiliations of authors Cancer Prevention Program ARK and SWOG Statistical Center AKD, CMT, PJG, Fred Hutchinson Cancer Research Center, Seattle, WA Department of Epidemiology ARK, GEG and Department of Environmental Health GEG, University of Washington, Seattle, WA University of Missouri, Research Reactor Center, Columbia, MO JSM Harry S Truman Memorial Veterans Hospital, Columbia, MO JSM Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX IMT Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA FLM Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD LMM, HLP Moores Cancer Center, University of California San Diego, San Diego, CA SML Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH EAK
J Natl Cancer Inst 106:djt456. 2014..This case-cohort study investigates effects of selenium and vitamin E supplementation conditional upon baseline selenium status...
- Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Scott M Lippman
The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
J Natl Cancer Inst 97:94-102. 2005....
- Patient-reported outcomes assessment in cancer trials: taking stock, moving forwardJoseph Lipscomb
Emory University, Atlanta, GA 30322, USA
J Clin Oncol 25:5133-40. 2007....
- Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Elise D Cook
Department of Clinical Cancer Prevention, Unit 1360, The University of Texas M D Anderson Cancer Center, Houston 77230 1439, USA
Clin Trials 2:436-42. 2005..The goal for black participants was set at 20% because of their proportion in the United States population and their prevalence of prostate cancer...